Metabolism

Items 451-500 of 5815

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Citations
  1. NAMPT inhibitor

    STF 118804 is a highly specific NAMPT inhibitor that reduces the viability of most B-ALL cell lines with high potency IC50 values in the low nanomolar range and improves survival in an orthotopic xenotransplant model of high-risk acute lymphoblastic leukemia.
  2. factor Xa inhibitor

    DPC423 is a highly potent and orally bioavailable pyrazole antithrombotic agent.
  3. C75

    FASN inhibitor

    C75 is a novel, potent synthetic inhibitor of fatty acid synthase (FAS), which is used as a tool for studying fatty acid synthesis in metabolic disorders and cancer.
  4. TrxR1/CRM1 inhibitor

    Piperlongumine selectively kills cancer cells regardless of p53 status without harming normal cells. It binds to and inihbits proteins known to regulate oxidative stress, in particular, Glutathione S-transferase pi 1 (GSTP1).
  5. RXR agonist

    LG 100268 is a potent RXR agonist for evaluation in the treatment of non-insulin-dependent (type II) diabetes mellitus (NIDDM).
  6. Grp94 Inhibitor

    PU-WS13 is a potent, Grp94-specific Hsp90 inhibitor of the purine scaffold class. PU-WS13 is a cell-permeable inhibitor of Grp94 with EC50 of 220 nM.
  7. XOR Inhibitor

    Topiroxostat (FYX-051) is a novel and potent xanthine oxidoreductase (XOR) inhibitor with IC50 value of 5.3 nM.
  8. PAI-1 inhbitor

    Tiplaxtinin is a selective and orally efficacious inhibitor of plasminogen activator inhibitor-1 (PAI-1) with IC50 of 2.7 μM.
  9. metalloendopeptidase inhibitor

    Phosphoramidon Disodium Salt is a metalloendopeptidase inhibitor.
  10. Lp-PLA2 Inhibitor

    Darapladib is a reversible lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor .
  11. HSP90 inhibitor

    CH5138303 is an orally available Hsp90 inhibitor with Kd of 0.48 nM.
  12. PFKFB3 inhibitor

    PFK15 is a potent and selective 6-phosphofructo-2-kinase (PFKFB3) with IC50 of 207 nM.
  13. HSP90 inhibitor

    NMS-E973 is a potent and selective Hsp90 inhibitor.
  14. Ribonucleotide reductase inhibitor

    Triapine is a potent ribonucleotide reductase inhibitor with broad spectrum antitumor activity by inhibiting DNA synthesis.
  15. Factor Xa inhibitor

    Edoxaban is a selective factor Xa inhibitor with Ki of 0.561 nM
  16. IDO inhibitor

    NLG919 is an orally available inhibitor of indoleamine 2,3-dioxygenase 1 (IDO1), with potential immunomodulating and antineoplastic activities.
  17. Tph1 inhibitor

    LP-533401 is a small molecule inhibitor of Tph1.
  18. Phospholipase C inhibitor

    U 73122 is a phospholipase C inhibitor. It inhibits agonist-induced platelet aggregation with IC50 values of 1-5 uM.
  19. MAO inhibitor

    RN-1 2HCl exhibits selectivity for LSD1 over monoamine oxidase (MAO)-A and MAO-B (IC50 values are 70 nM, 0.51 and 2.79 μM respectively, in a horseradish peroxidase-coupled assay).
  20. glucosidase I/II inhibitor

    Deoxynojirimycin is a Maltase-glucoamylase (a-glucosidase I and II) inhibitor. It interferes with N-linked glycosylation.
  21. Afegostat D-tartrate was an experimental drug for the treatment of certain forms of Gaucher's disease. The substance was used in form of the tartrate. Isofagomine (IFG) is an acid β-glucosidase (GCase) active site inhibitor that acts as a pharmacological chaperone.
  22. IDH1 inhibitor

    AG-120 is an orally available inhibitor of isocitrate dehydrogenase type 1 (IDH1), with potential antineoplastic activity.
  23. pan-HSP inhibitor

    KNK437, dose-dependently inhibited the acquisition of thermotolerance and the induction of various HSPs including HSP105, HSP70, and HSP40 in COLO 320DM (human colon carcinoma) cells.
  24. IDO inhibitor

    Indoximod is a methylated tryptophan with anti-immunosuppressive activity.
  25. PFK-2/FBPase inhibitor

    PFK-158 is an inhibitor of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases (PFK-2/FBPase) isoform 3 (PFKFB3) and derivative of 3-(3-pyridinyl)-1-[4-pyridinyl]-2-propen-1-one (3PO), with potential antineoplastic activity.
  26. FLAP inhibitor

    AZD6642 is an inhibitor of 5-Lipoxygenase Activating Protein (FLAP) for the treatment of inflammatory diseases.
  27. CAIX inhibitor/ radiosensitizer

    DTP348 is an oral dual CAIX inhibitor/ radiosensitizer.
  28. ASP9521 is a novel, selective, orally bioavailable inhibitor of 17??-hydroxysteroid dehydrogenase type 5 (17bHSD5, AKR1C3).
  29. FTase Inhibitor

    FTI-277 HCl is an inhibitor of farnesyl transferase (FTase); a highly potent Ras CAAX peptidomimetic which antagonizes both H- and K-Ras oncogenic signaling.
  30. Phytic Acid is a constituent of wheat bran shown to have antineoplastic action in colon carcinogenesis.
  31. 5-lipoxygenase inhibitor

    Esculetin, a phenolic compound, acts as a 5-LO (5-lipoxygenase, 5-LOX) inhibitor.
  32. Monoammoniumglycyrrhizinate is a constituent of the licorice root that has vital anti-viral activities that have been shown to inhibit the expression of 11_?HSD2 (11_?hydroxysteroid dehydrogenase type 2) via an indirect mechanism.
  33. Tyrosine hydroxylase inducer

    Panaxtriol is a tyrosine hydroxylase inducer.
  34. 3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.
  35. Peimisine and peiminine production by endophytic fungus Fusarium sp. isolated from Fritillaria unibracteata var. wabensis.
  36. Dihydroberberine is an inhibitor of pancreatic lipase with IC50 value of 8 mg/ml.
  37. AhR agonist

    Norisoboldine, an alkaloid compound isolated from Radix Linderae, inhibits synovial angiogenesis in adjuvant-induced arthritis rats by moderating Notch1 pathway-related endothelial tip cell phenotype.
  38. Ethyl Ferulate induces heme oxygenase-1 and protects rat neurons against oxidative stress.
  39. Licochalcone C was synthesized from commercially available 2,4-dihydroxybenzaldehde by using regioselective Al2O3-mediated C-prenylation followed by conventional Claisen-Schmidt condensation in basic condition.
  40. alpha-glucosidase inhibitor

    Voglibose is an N-substituted derivative of valiolamine, excellent inhibitory activity against alpha-glucosidases and its action against hyperglycemia and various disorders caused by hyperglycemia.
  41. Atractyloside is a natural heteroglucoside produced in some plants, including A. gummifera.
  42. PPAR agonist

    GW0742 is a selective agonist of PPARδ with EC50 value of 1.1 nM.
  43. Carbonic anhydrase (CA) inhibitor

    U-104 is a novel ureido-sulfonamide inhibitor of Carbonic Anhydrase IX (CAIX).
  44. (24R)-MC 976 is a Vitamin D3 derivative.
  45. 24R,25-Dihydroxyvitamin D3 is a vitamin D metabolite, a dihydroxylated form of the seco-steroid.
  46. (24S)-MC 976 is a Vitamin D3 derivative.
  47. 1alpha, 24, 25-Trihydroxy VD2 is a vitamin D analog.
  48. 1alpha, 25-Dihydroxy VD2-D6 is a deuterated form of vitamin D.
  49. 1alpha-Hydroxy VD4 , a 1alpha(OH)D derivative, can effectively induce the differentiation of monoblastic leukaemia U937, P39/TSU and P31/FUJ cells.

Items 451-500 of 5815

Page
per page
Set Descending Direction